Vera Therapeutics, Inc.

Healthcare · Biotechnology · United States

Last price 30.53 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 2.20B

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Vera Therapeutics, Inc., a clinical stage biotechnology company, focuses on the development and commercialization of transformative treatments for patients with immunological diseases. The company offers atacicept, a fully humanized TACI-Fc fusion protein that binds B-cell activating factor (BAFF) and A proliferation-inducing ligand (APRIL), which is self-administered at home as a subcutaneous injection being evaluated for the treatment of immunoglobulin A nephropathy (IgAN) and other autoimmune kidney diseases. It is also developing MAU868, a ...